Swiss National Bank’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-287,900
| Closed | -$613K | – | 2399 |
|
|
2024
Q4 | $613K | Buy |
287,900
+23,000
| +9% | +$49K | ﹤0.01% | 2365 |
|
|
2024
Q3 | $742K | Sell |
264,900
-22,100
| -8% | -$61.9K | ﹤0.01% | 2336 |
|
|
2024
Q2 | $669K | Buy |
287,000
+72,200
| +34% | +$168K | ﹤0.01% | 2345 |
|
|
2024
Q1 | $960K | Hold |
214,800
| – | – | ﹤0.01% | 2244 |
|
|
2023
Q4 | $690K | Buy |
214,800
+22,400
| +12% | +$71.9K | ﹤0.01% | 2411 |
|
|
2023
Q3 | $610K | Buy |
192,400
+5,600
| +3% | +$17.8K | ﹤0.01% | 2459 |
|
|
2023
Q2 | $928K | Hold |
186,800
| – | – | ﹤0.01% | 2331 |
|
|
2023
Q1 | $923K | Sell |
186,800
-21,600
| -10% | -$107K | ﹤0.01% | 2300 |
|
|
2022
Q4 | $1.31M | Buy |
208,400
+4,100
| +2% | +$25.8K | ﹤0.01% | 2173 |
|
|
2022
Q3 | $2.21M | Buy |
204,300
+2,500
| +1% | +$27K | ﹤0.01% | 1806 |
|
|
2022
Q2 | $2.3M | Buy |
201,800
+16,400
| +9% | +$187K | ﹤0.01% | 1815 |
|
|
2022
Q1 | $1.69M | Buy |
185,400
+13,400
| +8% | +$122K | ﹤0.01% | 2128 |
|
|
2021
Q4 | $2.57M | Hold |
172,000
| – | – | ﹤0.01% | 1893 |
|
|
2021
Q3 | $4.42M | Buy |
172,000
+1,500
| +0.9% | +$38.5K | ﹤0.01% | 1550 |
|
|
2021
Q2 | $4.45M | Buy |
170,500
+26,300
| +18% | +$686K | ﹤0.01% | 1583 |
|
|
2021
Q1 | $5.09M | Buy |
144,200
+2,500
| +2% | +$88.2K | ﹤0.01% | 1454 |
|
|
2020
Q4 | $3.58M | Buy |
141,700
+13,900
| +11% | +$351K | ﹤0.01% | 1569 |
|
|
2020
Q3 | $4.82M | Buy |
127,800
+2,400
| +2% | +$90.5K | ﹤0.01% | 1191 |
|
|
2020
Q2 | $5.37M | Buy |
125,400
+78,100
| +165% | +$3.34M | ﹤0.01% | 1106 |
|
|
2020
Q1 | $920K | Buy |
47,300
+700
| +2% | +$13.6K | ﹤0.01% | 1876 |
|
|
2019
Q4 | $1.21M | Buy |
46,600
+1,400
| +3% | +$36.4K | ﹤0.01% | 2028 |
|
|
2019
Q3 | $1.23M | Hold |
45,200
| – | – | ﹤0.01% | 1950 |
|
|
2019
Q2 | $1.21M | Buy |
+45,200
| New | +$1.21M | ﹤0.01% | 2009 |
|